Cost-Effectiveness of Crizotinib, Ceritinib, and Alectinib as First-Line Treatments for Anaplastic Lymphoma Kinase-Positive (ALK+) Metastatic Non-Small Cell Lung Cancer
2018 ◽
Vol 21
◽
pp. S32-S33
2019 ◽
Vol 40
(2)
◽
pp. 183-189
◽
Hongchao Li
◽
Lei Lai
◽
Bin Wu
V. Soares
◽
P. Orfanos
◽
C. Pereira
2018 ◽
Vol 36
(4)
◽
pp. 495-504
◽
Josh J. Carlson
◽
Kangho Suh
◽
Panos Orfanos
◽
William Wong
2019 ◽
Vol Volume 11
◽
pp. 9195-9202
◽
Maobai Liu
◽
Longfeng Zhang
◽
Qishu Huang
◽
Na Li
◽
Bin Zheng
◽
...
2018 ◽
Vol 14
(18)
◽
pp. 1875-1882
◽
2022 ◽
Vol 17
◽
pp. 101338
Xinru Chen
◽
Xiangchan Hong
◽
Gang Chen
◽
Jinhui Xue
◽
Jie Huang
◽
...
2017 ◽
Vol 9
(5)
◽
pp. E447-E450
2014 ◽
Vol 32
(10)
◽
pp. 983-985
◽
Ronan J. Kelly
◽
Bruce E. Hillner
◽
Thomas J. Smith
Jianya Zhou
◽
Jing Zheng
◽
Xiaochen Zhang
◽
Jing Zhao
◽
Yanping Zhu
◽
...
2015 ◽
Vol 18
(7)
◽
pp. A462
◽
Z Zhou
◽
M Hurry
◽
J Zhang
◽
L Fan
◽
C Zhang
◽
...
Close
Export Citation Format
Close
Share Document
Close